Correlation Between Mesoblast and Northwest Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Mesoblast and Northwest Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mesoblast and Northwest Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mesoblast and Northwest Biotherapeutics, you can compare the effects of market volatilities on Mesoblast and Northwest Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mesoblast with a short position of Northwest Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mesoblast and Northwest Biotherapeutics.

Diversification Opportunities for Mesoblast and Northwest Biotherapeutics

0.46

Correlation Coefficient

Mesoblast  Northwest Biotherapeutics

Very weak diversification

The 3 months correlation between Mesoblast and Northwest is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Mesoblast and Northwest Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Northwest Biotherapeutics and Mesoblast is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mesoblast are associated (or correlated) with Northwest Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Northwest Biotherapeutics has no effect on the direction of Mesoblast i.e., Mesoblast and Northwest Biotherapeutics go up and down completely randomly.

Pair Corralation between Mesoblast and Northwest Biotherapeutics

Given the investment horizon of 90 days Mesoblast is expected to under-perform the Northwest Biotherapeutics. In addition to that, Mesoblast is 1.31 times more volatile than Northwest Biotherapeutics. It trades about -0.06 of its total potential returns per unit of risk. Northwest Biotherapeutics is currently generating about -0.02 per unit of volatility. If you would invest  27.00  in Northwest Biotherapeutics on December 23, 2024 and sell it today you would lose (2.00) from holding Northwest Biotherapeutics or give up 7.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	96.72%
Values	Daily Returns

Mesoblast  vs.  Northwest Biotherapeutics

Mesoblast

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mesoblast has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Northwest Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Northwest Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Northwest Biotherapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Mesoblast and Northwest Biotherapeutics

The main advantage of trading using opposite Mesoblast and Northwest Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mesoblast position performs unexpectedly, Northwest Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Northwest Biotherapeutics will offset losses from the drop in Northwest Biotherapeutics' long position.

The idea behind Mesoblast and Northwest Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.